← Evidence map

ArticleJCI insight2023

A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disorders.

Lingjun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37917882